Mark Kirby

Mark has a background in early-stage medtech companies, supporting them from start-up to successful exit via trade sale and flotation. Most recently he has held various roles as Chairman or CEO of high potential MedTech start-ups and he chairs a panel of the NIHR i4i translational funding scheme for the advancement of healthcare technologies for NHS patients.

He began his career as a chartered mechanical engineer before joining the medical device start-up, Medic-Aid Ltd, where, as CEO, he led the company to a management buyout and subsequently listing on the Main Market of the London Stock Exchange before completing a trade sale to Respironics Inc. Since selling his business he has chaired several MedTech start-ups and he successfully sold Nigaard Pharma A/S to Zambon Spa in 2015.